---
id: travel-medicine-essentials_120
category: travel-medicine
tags: [travel-medicine, malaria-prophylaxis, travelers-diarrhea, yellow-fever, pre-travel-consultation]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Travel Medicine Essentials

**Q:** What are the key components of a pre-travel consultation, travel-specific vaccines, malaria prophylaxis options, and approach to travelers' diarrhea?

**A:**

## PRE-TRAVEL CONSULTATION

**Timing:** **4-6 weeks before departure** (allows time for multi-dose vaccines to take effect)

**Key Components:**

1. **Itinerary Assessment**
   - **Destination(s)** (urban vs rural)
   - **Duration** of travel
   - **Activities** (adventure travel, safari, water exposure)
   - **Accommodations** (hotel vs camping)
   - **Season** (rainy season → mosquito-borne diseases)

2. **Medical History**
   - **Immunocompromised status** (live vaccines contraindicated)
   - **Pregnancy** (avoid live vaccines, malaria prophylaxis restrictions)
   - **Chronic conditions** (diabetes, cardiovascular disease)
   - **Allergies** (egg allergy → yellow fever vaccine)

3. **Vaccination Status**
   - **Routine vaccines** (measles, tetanus, influenza)
   - **Travel-required vaccines** (yellow fever, meningococcus)
   - **Travel-recommended vaccines** (hepatitis A/B, typhoid, rabies, JE)

4. **Counseling**
   - **Food/water precautions** ("Boil it, cook it, peel it, or forget it")
   - **Insect bite prevention** (DEET, permethrin-treated clothing)
   - **Travelers' diarrhea self-treatment**
   - **Altitude illness prevention** (if high-altitude travel)

**Key Point:** **Pre-travel consult 4-6 weeks before departure** (allows vaccine series completion)

---

## TRAVEL VACCINES

### **ROUTINE VACCINES (Ensure Up-to-Date)**

- **Measles, mumps, rubella (MMR)** - 2 doses (live vaccine)
- **Tetanus, diphtheria, pertussis (Tdap)** - booster every 10 years
- **Influenza** - annual (especially if traveling during flu season)
- **Pneumococcal** (PCV20, PPSV23) - if ≥65 years or risk factors
- **COVID-19** - per current CDC recommendations

**Key Point:** **Measles = most common vaccine-preventable disease in travelers** (ensure 2 doses MMR)

---

### **REQUIRED VACCINES**

**1. YELLOW FEVER**

**Indications:**
- **Required for entry** to certain countries (sub-Saharan Africa, South America)
- **Recommended for travelers** to endemic areas

**Vaccine:** **YF-VAX** - **single dose** (provides lifelong immunity)

**Timing:** **≥10 days before travel** (for immunity to develop)

**Contraindications:**
- **Age <6 months** (absolute)
- **Egg allergy** (severe)
- **Immunocompromised** (HIV with CD4 <200, thymus disorder)
- **Age ≥60 years** (increased risk of viscerotropic disease)

**Documentation:** **International Certificate of Vaccination (ICV)** - "yellow card" (valid for life)

**Key Point:** **Yellow fever vaccine required for entry to endemic countries** (valid for life)

---

**2. MENINGOCOCCAL VACCINE**

**Indications:**
- **Required for Hajj pilgrimage** (Saudi Arabia)
- **Recommended for travel to "meningitis belt"** (sub-Saharan Africa during dry season, December-June)

**Vaccine:**
- **MenACWY** (quadrivalent - serogroups A, C, W, Y) - **single dose**
- **MenB** (serogroup B) - if high-risk travel

**Key Point:** **Meningococcal vaccine required for Hajj** (Saudi Arabia entry requirement)

---

### **RECOMMENDED VACCINES**

**1. HEPATITIS A**

**Indications:** **ALL travelers to developing countries** (most common vaccine-preventable infection in travelers)

**Vaccine:** **Havrix, Vaqta** - 2 doses (0, 6-12 months)

**Timing:** 1st dose provides protection within 2 weeks (protective for travel even without 2nd dose)

**Key Point:** **Hepatitis A = #1 recommended travel vaccine** (all travelers to developing countries)

---

**2. TYPHOID**

**Indications:** Travel to **South Asia** (especially India, Pakistan, Bangladesh), sub-Saharan Africa

**Vaccine Options:**

| **Vaccine** | **Type** | **Dosing** | **Duration of Protection** |
|-------------|----------|------------|---------------------------|
| **Typhim Vi** (injectable) | Inactivated (Vi polysaccharide) | **Single IM dose** | **2 years** |
| **Vivotif** (oral) | **Live attenuated** | **4 capsules PO** (every other day) | **5 years** |

**Key Point:** **Oral typhoid vaccine = live** (contraindicated if immunocompromised, on antibiotics)

---

**3. RABIES (Pre-Exposure Prophylaxis)**

**Indications:**
- **High-risk activities** (spelunking, veterinary work)
- **Limited access to post-exposure prophylaxis** (remote travel)
- **Children** (higher risk of animal bites)

**Vaccine:** **3 doses IM** (days 0, 7, 21-28)

**Post-Exposure (if Pre-Exposure Vaccination Given):**
- **2 doses** (days 0, 3) - **NO rabies immune globulin (RIG) needed**

**Key Point:** **Pre-exposure rabies vaccination simplifies post-exposure management** (no RIG needed)

---

**4. JAPANESE ENCEPHALITIS (JE)**

**Indications:** Travel to **rural Asia** (especially rice paddies, pig farming areas) for **≥1 month**

**Vaccine:** **Ixiaro** - 2 doses IM (days 0, 28)

**Key Point:** **JE vaccine for rural Asia travel ≥1 month** (rice paddies, rainy season)

---

**5. HEPATITIS B**

**Indications:** Healthcare work, high-risk activities (tattoos, medical procedures)

**Vaccine:** **3 doses IM** (0, 1, 6 months)

**Accelerated schedule:** 0, 7, 21 days + booster at 12 months (if departure imminent)

---

## MALARIA PROPHYLAXIS

**Mnemonic: "ABCD" (Awareness, Bite prevention, Chemoprophylaxis, Diagnosis)**

### **Chemoprophylaxis Options:**

| **Agent** | **Dosing** | **Start** | **Continue** | **Advantages** | **Disadvantages** |
|-----------|------------|-----------|--------------|----------------|-------------------|
| **Atovaquone-proguanil (Malarone)** | **250/100 mg PO daily** | **1-2 days before** | **7 days after** | **Short tail** (7 days after), well-tolerated | **Expensive** |
| **Doxycycline** | **100 mg PO daily** | **1-2 days before** | **28 days after** | **Cheap**, covers other infections (rickettsiae, leptospirosis) | **GI upset, photosensitivity** |
| **Mefloquine** | **250 mg PO weekly** | **2-3 weeks before** | **4 weeks after** | **Weekly dosing** | **Neuropsychiatric side effects** (contraindicated if psychiatric history, seizures) |
| **Chloroquine** | **500 mg PO weekly** | **1-2 weeks before** | **4 weeks after** | **Safe in pregnancy** | **Limited efficacy** (only for chloroquine-sensitive areas) |

**Key Point:** **Atovaquone-proguanil = preferred** (short tail, well-tolerated, but expensive)

---

### **Malaria Prophylaxis by Region:**

| **Region** | **Resistance Pattern** | **Preferred Prophylaxis** |
|------------|------------------------|---------------------------|
| **Sub-Saharan Africa** | Chloroquine-resistant *P. falciparum* | **Atovaquone-proguanil, doxycycline, OR mefloquine** |
| **Southeast Asia** | Chloroquine-resistant *P. falciparum* + mefloquine resistance (Thailand-Myanmar border) | **Atovaquone-proguanil OR doxycycline** |
| **Central America, Caribbean** | Chloroquine-sensitive (mostly *P. vivax*) | **Chloroquine** |
| **South America** | Chloroquine-resistant *P. falciparum* | **Atovaquone-proguanil OR doxycycline** |

**Key Point:** **Most malaria-endemic areas = chloroquine-resistant** (atovaquone-proguanil or doxycycline)

---

## TRAVELERS' DIARRHEA

**Definition:** ≥3 unformed stools in 24 hours + ≥1 symptom (abdominal cramps, nausea, vomiting, fever)

**Incidence:** **30-70%** of travelers to developing countries

**Common Pathogens:**
- **Bacteria (80%):** *E. coli* (ETEC = #1), *Campylobacter, Shigella, Salmonella*
- **Viruses (10%):** Norovirus, rotavirus
- **Parasites (10%):** *Giardia, Cryptosporidium, Entamoeba*

---

### **Prevention:**

**Food/Water Precautions:**
- **Mnemonic: "Boil it, cook it, peel it, or forget it"**
- **Avoid:** Tap water, ice, raw vegetables, undercooked meat/seafood, street food

**Antibiotic Prophylaxis (NOT Routinely Recommended):**
- **Consider ONLY if:** High-risk travel + immunocompromised OR critical itinerary (athletes, diplomats)
- **Agent:** Rifaximin 200 mg PO daily

**Key Point:** **Rifaximin prophylaxis ONLY for high-risk travelers** (not routine)

---

### **Treatment:**

**Mild (No Systemic Symptoms):**
- **Loperamide** 4 mg PO x 1 → 2 mg PO after each loose stool (max 16 mg/day)
- **Bismuth subsalicylate** 524 mg PO q30-60 min (max 8 doses/day)

**Moderate-Severe (Dysentery, Fever, Bloody Stools):**

| **Scenario** | **Treatment** |
|--------------|---------------|
| **Standard travelers' diarrhea** | **Azithromycin 1000 mg PO x 1 dose** OR **500 mg PO daily x 3 days** |
| **Fluoroquinolone-sensitive area** (not South/Southeast Asia) | **Ciprofloxacin 750 mg PO x 1 dose** OR **500 mg PO BID x 3 days** |
| **Suspected *Giardia*** (prolonged, foul-smelling, after 7-10 days) | **Metronidazole 500 mg PO TID x 7 days** OR **tinidazole 2g PO x 1 dose** |

**Key Point:** **Azithromycin = 1st-line for travelers' diarrhea** (fluoroquinolone resistance common in Asia)

---

## HIGH-ALTITUDE ILLNESS

**Acute Mountain Sickness (AMS):**
- **Symptoms:** Headache + ≥1 (nausea, fatigue, dizziness)
- **Onset:** 6-12 hours after ascent to >2500 m (8000 ft)

**Prevention:**
- **Gradual ascent** (limit 300-500 m/day above 3000 m)
- **Acetazolamide** 125 mg PO BID (start 1 day before ascent → continue 2 days at altitude)

**Treatment (AMS):**
- **Descend** (if severe)
- **Acetazolamide** 250 mg PO BID
- **Dexamethasone** 4 mg PO/IM q6h (if severe)

**Key Point:** **Acetazolamide 125 mg BID for altitude prophylaxis** (start 1 day before ascent)

---

## DENGUE PREVENTION

**No vaccine widely available in US** (Dengvaxia only for seropositive individuals 9-16 years in endemic areas)

**Prevention:**
- **Mosquito bite prevention:** DEET, permethrin-treated clothing
- **Peak biting:** Daytime (Aedes mosquitoes)

**Key Point:** **No effective dengue vaccine for travelers** (bite prevention only)

---

## SPECIAL POPULATIONS

**IMMUNOCOMPROMISED TRAVELERS:**
- **Avoid live vaccines** (yellow fever, oral typhoid, MMR, varicella)
- **Inactivated vaccines safe** (may have reduced efficacy)
- **Yellow fever waiver letter** (if vaccine contraindicated)

**PREGNANT TRAVELERS:**
- **Avoid live vaccines** (yellow fever, MMR)
- **Malaria prophylaxis:** Chloroquine, mefloquine (safe), atovaquone-proguanil (avoid 1st trimester), **AVOID doxycycline**
- **Defer travel to Zika-endemic areas** (risk of congenital Zika syndrome)

**Key Point:** **Pregnant: Avoid doxycycline, defer Zika-endemic travel**

---

**Clinical Pearls:**
- **Pre-travel consult 4-6 weeks before departure** (multi-dose vaccine series)
- **Hepatitis A = #1 recommended vaccine** (all travelers to developing countries)
- **Yellow fever vaccine valid for life** (10 days before travel for immunity)
- **Atovaquone-proguanil = preferred malaria prophylaxis** (short 7-day tail, well-tolerated)
- **Azithromycin = 1st-line for travelers' diarrhea** (fluoroquinolone resistance in Asia)
- **Oral typhoid vaccine = live** (contraindicated if immunocompromised)
- **Pre-exposure rabies vaccination = no RIG needed** (simplifies post-exposure management)
- **Mefloquine contraindicated** if psychiatric history or seizures
- **Acetazolamide 125 mg BID for altitude prophylaxis** (start 1 day before)
- **Pregnant travelers: Avoid doxycycline, defer Zika-endemic areas**

**Media:** None

**Sources:** [CDC Yellow Book 2024], [CDC Travelers' Health 2024]
